Across TCGA pan-cancer cohorts, RNU6-1152P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6-1152P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU6-1152P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-1152P is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

BRCA, ESCA, and COAD are the cancer types where RNU6-1152P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-1152P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.206	.011	6	view →
ESCA	All	II,III,IV	+1.055	.015	2	view →
COAD	All	II,III,IV	+0.118	.025	2	view →
KICH	All	All	−0.101	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-1152P RNA expression & survival · all RNU6-1152P data types